Guardant Health Financial Ratios
NASDAQ: GHHealth CareMedical SpecialitiesUSD
167.47+1.91 (+1.15%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Guardant Health ratio analysis
Guardant Health earned a net margin of -42.4% in FY 2025, up from -59.0% a year earlier. Gross margin was 64.5% compared with a median of 60.3% over the prior 2 years. Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.
Summary generated from market data by MetaCap's automated system. Methodology
Guardant Health financial ratios (annual)
| Ratio | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Price / sales | 12.99 | 5.61 | 5.37 | 6.18 | 27.12 | 43.83 | 33.12 | 12.14 | — |
| Price / book | — | — | 19.09 | 46.18 | 15.71 | 9.68 | 8.89 | 2.28 | — |
| Gross margin | 64.5% | 60.8% | 59.7% | — | — | — | — | — | — |
| Operating margin | -44.5% | -60.0% | -100.1% | -121.1% | -110.0% | -88.9% | -38.4% | -102.5% | -153.7% |
| Net margin | -42.4% | -59.0% | -85.0% | -145.6% | -103.0% | -85.9% | -35.3% | -93.8% | -167.0% |
| Free cash flow margin | -23.7% | -37.2% | -61.3% | -86.1% | -76.0% | -48.9% | -30.7% | -101.9% | -158.3% |
| Return on equity (ROE) | — | — | -302.1% | -1,087.7% | -59.7% | -19.0% | -9.5% | -17.6% | -27.0% |
| Return on assets (ROA) | -20.7% | -29.4% | -26.8% | -40.7% | -17.5% | -10.8% | -7.9% | -14.5% | -24.3% |
| Current ratio | 4.84 | 4.68 | 6.54 | 6.17 | 5.72 | 28.27 | 8.21 | 9.99 | 12.38 |
| Revenue growth | 32.9% | 31.0% | 25.5% | 20.3% | 30.3% | 33.8% | 136.5% | 81.9% | — |